Clover Health Investments, Corp. (NASDAQ:CLOV) Stock Position Trimmed by Kestra Private Wealth Services LLC

Kestra Private Wealth Services LLC decreased its position in Clover Health Investments, Corp. (NASDAQ:CLOV) by 41.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 13,525 shares of the company’s stock after selling 9,500 shares during the period. Kestra Private Wealth Services LLC’s holdings in Clover Health Investments were worth $49,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Graham Capital Management L.P. bought a new position in Clover Health Investments in the 4th quarter valued at about $889,000. Marshall Wace LLP boosted its holdings in shares of Clover Health Investments by 167.6% in the fourth quarter. Marshall Wace LLP now owns 3,769,765 shares of the company’s stock valued at $11,875,000 after acquiring an additional 2,360,902 shares in the last quarter. Barclays PLC increased its stake in shares of Clover Health Investments by 336.5% during the fourth quarter. Barclays PLC now owns 461,692 shares of the company’s stock valued at $1,454,000 after acquiring an additional 355,926 shares during the period. JPMorgan Chase & Co. raised its holdings in Clover Health Investments by 172.0% during the fourth quarter. JPMorgan Chase & Co. now owns 432,268 shares of the company’s stock worth $1,362,000 after purchasing an additional 273,348 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in Clover Health Investments by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 19,585,213 shares of the company’s stock worth $61,693,000 after purchasing an additional 386,499 shares during the period. Institutional investors own 19.77% of the company’s stock.

Clover Health Investments Stock Performance

Shares of NASDAQ CLOV opened at $2.89 on Wednesday. Clover Health Investments, Corp. has a 1 year low of $1.50 and a 1 year high of $4.87. The stock has a fifty day moving average price of $2.99 and a two-hundred day moving average price of $3.55. The firm has a market cap of $1.47 billion, a P/E ratio of -57.80 and a beta of 1.86.

Clover Health Investments (NASDAQ:CLOV) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.12. Clover Health Investments had a negative net margin of 1.69% and a negative return on equity of 7.42%. The company had revenue of $462.33 million during the quarter, compared to the consensus estimate of $466.93 million. On average, research analysts predict that Clover Health Investments, Corp. will post -0.12 earnings per share for the current fiscal year.

Insider Activity at Clover Health Investments

In related news, CEO Conrad Wai sold 91,197 shares of the firm’s stock in a transaction that occurred on Wednesday, July 23rd. The shares were sold at an average price of $3.32, for a total transaction of $302,774.04. Following the completion of the sale, the chief executive officer directly owned 1,403,701 shares in the company, valued at approximately $4,660,287.32. This trade represents a 6.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 24.07% of the stock is owned by insiders.

Clover Health Investments Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.